CROSS-REFERENCE TO RELATED APPLICATIONSThis is a Divisional application of co-pending U.S. application Ser. No. 13/908,387 filed Jun. 3, 2013.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENTNot Applicable
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ON A COMPACT DISCNot Applicable
BACKGROUND OF THE INVENTION1. Field of the Invention
The present invention relates generally to medicament administration. More particularly, the invention concerns a novel fluid medicament delivery apparatus that is specially designed to facilitate the aseptic administration of drugs to patients.
2. Description of Related Art Including Information Disclosed Under 37 CFR 1.97 and 1.98
Medicaments intended for parenteral administration are typically stored in a medicament container in either in liquid, powdered or lyophilized form. Typically, lyophilized drugs are packaged in standard glass vials that are sealed with a pierceable rubber stopper and a crimped metal cap. A suitable liquid diluent must be added to the vial to reconstitute the powdered or lyophilized drug before use. In accordance with typical prior art methods, this reconstitution step was accomplished by drawing a measured amount of diluent, such as water, into a syringe from a diluent vial. The sealed vial containing the powdered or lyophilized drug was then accessed using a hypodermic needle and syringe to add the liquid diluent to the vial. The vial was then in inverted and shaken to intermix the drug with the liquid diluent. This done, the reconstituted drug was withdrawn into the syringe and was injected into the patient.
It is apparent that when reconstitution of a drug is required, the prior art processes required at least two fluid transfers. The problem of ensuring proper fluid transfer under acceptable aseptic conditions during these two fluid transfers was formidable and was especially acute in the case of self-administration of drugs by patients in a homecare environment. For example, during the fluid transfers, the rubber stopper that is disposed within the top of the vial must be penetrated by the syringe needle. Typically, the rubber stopper is not sterile and, accordingly, the exposed needle is exposed to non-sterile conditions. Furthermore, as the needle penetrates the rubber stopper it will inevitably become contaminated with small particles of rubber that are dislodged from the rubber stopper during the needle penetration step. Additionally, this two-step process is quite cumbersome for physicians and particularly for homecare caregivers to accomplish, often under the stressful conditions that frequently exist at the bedside of a patient.
One approach to overcoming the drawbacks of the prior art methods as described in the preceding paragraphs is disclosed in U.S. Pat. No. 6,238,372 to issued to Zinger et al. The Zinger et al. patent discloses a drug vial mixing and transfer device having one or more ports with interconnecting fluid passageways. The ends of the ports are attached either to a piercing connector or a syringe. The piercing connector is used to support and penetrate the rubber stoppers of the standard glass drug vials that are filled with powdered or lyophilized drugs or a liquid diluent during the transfer of the liquid diluent and drug solutions between the vials and the syringe. In one form of the invention, the ports and connectors are mounted on a base and a stopcock type valve is used to coordinate communication between the fluid passageways of the different ports. Retainers mounted on the base hold the syringe and vials in place during the liquid transfer operations.
BRIEF SUMMARY OF THE INVENTIONBy way of summary, the present invention concerns a disposable shrouded vial adapter with a preconnected, integral “med push” hypodermic needle for low-cost, economical reconstitution of lyophilized drugs and for the direct injection of the reconstituted drug into the patient. In one form of the invention, the apparatus comprises a syringe assembly and a novel adapter assembly that can be removably connected to a medicament container or vial containing a liquid medicament, a powdered medicament or a lyophilized medicament. The syringe assembly of the apparatus includes an aspirator component that includes a body portion having a forward end and a piston slidably carried within the body portion to form a liquid chamber between the forward end of the body portion and the piston. The aspirator connector component of the syringe assembly, which comprises a syringe cannula assembly, is adapted to be removably interconnected with the aspirator component. This novel aspirator connector component comprises a cannula support and a syringe cannula connected to the cannula support.
In one form of the invention the adapter assembly comprises an adapter, preferably molded from a moldable plastic, that includes a body portion having a tapered bore, a top wall connected to the body portion, an adapter cannula connected to and extending from the body portion and a container connector means connected to the top wall for removably interconnecting the adapter with the medicament container. The container connector means can be of various configurations that telescopically receive and securely grip the upper portion of the medicament container. Uniquely, when the cannula support portion of the aspirator connector component is sealably received within the tapered bore of the body portion of the adapter assembly, the syringe cannula portion of the aspirator connector component is strategically positioned within the lumen of the adapter cannula where it is completely shielded from external contamination.
It is an object of the present invention to provide a method and apparatus for reconstituting a lyophilized drug and for then delivering the reconstituted drug to a patient. The method of the invention makes use of an apparatus of the character described in the preceding paragraph and is carried out in a manner such that the hypodermic syringe component of the apparatus is at all times protected from external contaminants and need not be used to penetrate the rubber stopper of the medicament container containing the drug that is to be reconstituted.
Another object of the invention is to provide a method of the aforementioned character in which off-the-shelf syringe body components that have been pre-filled with a suitable diluent can be used to accomplish the reconstitution step of the method of the invention.
Another object of the invention is to provide apparatus of the class described in which the adapter component includes filter means for filtering the fluid that is aspirated from the medicament container.
Another object of the invention is to provide apparatus of the class described in which the adapter component includes vent means for venting to atmosphere any gases that may be contained within the medicament container.
Another object of the invention is to provide an alternate form of the apparatus of the invention that comprises three cooperating components, namely a somewhat differently configured adapter component, a uniquely configured needle sheath for holding and protecting the needle and a differently configured a syringe connector assembly.
Another object of the invention is to provide apparatus of the character described in the preceding paragraph that includes a positive locking needle sheath that protects the user from accidental needle stick injury, from needle point damage and from needle point contamination when removed from the vial adapter in preparation for patent injection.
Another object of the invention is to provide apparatus of the character described in the preceding paragraphs that provides a cost-effective method for safely reconstituting a drug for use and for maintaining a safe environment during drug reconstitution and following removal of the needle from the vial adapter in preparation for patient injection.
Another object of the invention is to provide apparatus of the class described herein that is of a simple design and is easy use in both hospital and homecare environments.
Another object of the invention is to provide an apparatus as described in the preceding paragraph which can be inexpensively manufactured so that the apparatus can be economically disposed of after use.
Another object of the invention is to provide apparatus of the class described herein that can conveniently be used to reconstitute and deliver a wide variety of medicaments in various selected doses.
BRIEF DESCRIPTION OF SEVERAL VIEWS OF THE DRAWINGSFIG. 1 is a side elevational view, partly in cross-section showing one form of the vial accessing adapter subassembly of the invention for use in administering medicaments to a patient.
FIG. 2 is a view is similar toFIG. 1, but showing the vial accessing adapter subassembly positioned over and interconnected with a conventional medicament container or vial that is shown in phantom.
FIG. 2A is an enlarged view similar toFIG. 2, but illustrating in cross-section the area designated inFIG. 2 as2A.
FIG. 3 is a view partly in cross section of the accessing adapter subassembly and the syringe body that can be operably interconnected with the accessing adapter subassembly to form the syringe assembly that is used to accomplish the fluid transfer steps.
FIG. 3A is a view similar toFIG. 3, but showing the syringe assembly separated from the adapter component of the accessing adapter assembly.
FIG. 4 is a fragmentary cross-sectional view of an alternate form of the vial accessing adapter subassembly of the apparatus of the invention that includes filter means for filtering the fluid withdrawn from the medicament container.
FIG. 4A is a greatly enlarged, cross-sectional view taken alonglines4A-4A ofFIG. 4.
FIG. 5 is a cross-sectional view of another form of the adapter component of the vial accessing adapter means of the invention that includes venting means for venting to atmosphere gases contained within the medicament container.
FIG. 5A is an enlarged, cross-sectional view of the area designated inFIG. 5 as5A.
FIG. 6 is a cross-sectional view of still another form of the vial accessing adapter means of the invention having an adapter component of a different configuration.
FIG. 7 is a cross-sectional view of yet another form of the vial accessing adapter means of the invention having an adapter component that includes a circumferentially extending, neck-gripping bead.
FIG. 8 is a cross-sectioned view of still another form of vial accessing adapter means of the invention for the aseptic administration of medicaments contained within a medicament container.
FIG. 9 is a cross-sectional view of yet another form of vial accessing adapter means for accessing a medicament container.
FIG. 10 is a cross-sectional view of one form of the aspirator connector means, or syringe cannula assembly of the embodiment of the invention shown inFIG. 9.
FIG. 10A is a cross-sectional view of an alternate form of the aspirator connector means, or syringe cannula assembly of the invention.
FIG. 11 is a side elevational view of the needle sheath subassembly of the embodiment of the invention shown inFIG. 9.
FIG. 12 is a cross-sectional view taken along lines12-12 ofFIG. 11.
FIG. 12A is a cross-sectional view of the assemblage made up of the needle sheath assembly and the aspirator connector means.
FIG. 13 is an enlarged cross-sectional view of the adapter component of the embodiment of the invention shown inFIG. 9.
FIG. 14 is a top plan view of the assemblage made up of the adapter component and needle sheath subassembly of the embodiment of the invention shown inFIG. 9.
FIG. 15 is a generally perspective view of the assembly made up of the adapter component and needle sheath subassembly.
FIG. 16 is a side elevational view, partly in cross-section showing yet another form of the vial accessing adapter subassembly of the invention for use in administering medicaments to a patient.
FIG. 17 is a side elevational exploded view, partly in cross-section of the vial accessing adapter subassembly illustrated inFIG. 16.
FIG. 18 is a side elevational view, partly in cross-section showing still another form of the vial accessing adapter subassembly of the invention for use in administering medicaments to a patient.
FIG. 19 is a side elevational exploded view, partly in cross-section of the vial accessing adapter subassembly illustrated inFIG. 18.
FIG. 20 is a generally perspective view of yet another form of the adapter component of yet another form of the vial accessing adapter subassembly of the invention.
FIG. 21 is a side elevational view, partly in cross-section showing the form of vial accessing adapter subassembly of the invention that embodies the adapter component shown inFIG. 20.
FIG. 22 is a side elevational exploded view, partly in cross-section of the vial accessing adapter subassembly illustrated inFIG. 21.
FIG. 23 is a cross-sectional view of an alternate form of needle sheath component of the vial accessing adapter subassembly of the invention.
FIG. 24 is a cross-sectional view of still another form of needle sheath component of the vial accessing adapter subassembly of the invention.
FIG. 25 is a side elevational view, partly in cross-section showing the form of vial accessing adapter subassembly of the invention that embodies the needle sheath component shown inFIG. 24.
FIG. 26 is a cross-sectional view of yet another form of needle sheath component of the vial accessing adapter subassembly of the invention.
FIG. 27 is a side elevational view, partly in cross-section showing the form of vial accessing adapter subassembly of the invention that embodies the needle sheath component shown inFIG. 26.
DETAILED DESCRIPTION OF THE INVENTIONReferring to the drawings and particularly toFIGS. 1 and 2, one form of the vial accessing adapter means of the invention for the aseptic administration of medicaments contained within a medicament container is there shown. The vial-accessing adapter means here comprises a vial accessingadapter subassembly12 that includes anadapter component14 that is preferably formed from a moldable plastic material.Adapter component14 includes abody portion15 having a tapered bore15a,atop wall16 connected to the body portion and anadapter cannula18 that is integrally formed with and extends frombody portion15. A container connector means is also connected totop wall16 and functions to removably interconnect the adapter component with a conventional medicament container MC (FIG. 2). The container connector means of the present form of the invention here comprises a resilientlydeformable skirt20 that is integrally formed with and extends fromtop wall16 in the manner shown in the drawings. As best seen inFIG. 2, when the adapter component is mated with the medicament container,skirt20 telescopically receives and securely grips the upper portion of the medicament container in a manner such thatadapter cannula18 will completely pierce the rubber stopper RS of the container (FIG. 2A). Rubber stopper RS is secured in position within the upper portion of the container in a conventional manner by a crimp ring CR.
As illustrated inFIG. 2A,plastic adapter cannula18 has a piercingextremity18aand alumen18bthat communicates with the interior of the medicament container MC when the adapter component is interconnected with the container in the manner shown inFIG. 2A. In this regard, it is to be noted thatskirt20 is provided with a radially inwardly extendingshoulder20aand a plurality of circumferentially spacedslits20bthat enable the adapter component of the invention to be snapped over the upper portion of the medicament container MC to securely grip the container in the manner shown inFIG. 2.
In the present form of the invention,body portion15 of the vial accessing adapter means functions to interconnect the syringe assembly24 (FIG. 3A) of the apparatus of the invention with the medicament container MC. As illustrated inFIG. 3, thisimportant syringe assembly24 is made up of an aspirator means shown here assyringe body25 and an aspirator connector means, orsyringe cannula assembly26, that can be sealably connected tobody portion15 of the vial accessing adapter means of the invention. The aspirator means orsyringe body25 includes abarrel portion28 having aforward end28aand apiston30 that it is slidably carried within the barrel portion. As in conventional syringes, aliquid chamber32 is formed between theforward end28aof the barrel portion of the syringe body andpiston30.
Removably connected to the aspirator means orsyringe body25 is the previously mentioned aspirator connector means orsyringe cannula assembly26 that includes asyringe cannula support41 and asyringe cannula42 that is integrally formed with thesyringe cannula support41. As best seen inFIG. 2, syringe oraspirator cannula42 is here shown as a hypodermic needle having alumen42a.As shown inFIG. 3,syringe cannula assembly26, which is removably connected tosyringe body portion25 of the syringe assembly, is sealably receivable within the tapered bore15aof body potion. It is important to note that when thesyringe cannula support41 of thecannula assembly26 is sealably connected tobody portion15 in the manner shown inFIG. 2, the syringe cannula orhypodermic needle42 is strategically positioned withinlumen18aof theadapter cannula18 and is, therefore, protected from contamination, including contamination by the rubber stopper of the medicament container.
Thesyringe cannula support41 ofcannula assembly26 is also provided with barrel connection means for connecting the assembly with theforward end28 of thebarrel portion26 of thesyringe body25. This barrel connection means is here provided in the form of aconventional luer48 formed oncannula support41. As shown in the phantom lines ofFIG. 3A, luer48 is threadably receivable withininternal threads28aprovided theforward end28bof thebarrel portion28. Once thesyringe cannula assembly26 is interconnected with thesyringe body25, thesyringe assembly24 thus formed functions in the same manner as a conventional medicament administration syringe and, in the manner presently to be described, can be used to reconstitute lyophilized drugs and to administer medicaments to a patient in a conventional manner.
It is to be understood that the medicament container MC can contain a fluid medicament or, alternatively, can contain a medicament in a powdered or lyophilized form. As previously mentioned, when the medicament is in a powdered or lyophilized form a suitable liquid diluent must be added to the container to reconstitute the powdered or lyophilized drug before use. In accordance with one form of the method of the present invention, this can be accomplished by first accessing the sealed container of powdered or lyophilized drug using the vial accessing adapter means that is made up ofadapter14 andsyringe cannula assembly26. This accessing step is accomplished by placing the vial accessingadapter subassembly12 over the medicament container MC and exerting a downward force on the subassembly sufficient to causeadapter cannula18 to pierce the rubber stopper in the manner shown inFIG. 2A. With the components in the position shown inFIG. 2A, is to be observed that thelumen18aofcannula18 as well as thelumen42aof piercingcannula42 are in communication with the interior of medicament container MC.
With the vial accessingadapter subassembly12 appropriately interconnected with the medicament container MC, the assemblage thus formed is inverted and a sealedsyringe body25 that has been prefilled with a suitable diluent opens and is then connected to the vial accessing adapter means by means of theluer connector48 formed onmember41. The prefilled, sealed syringe body, which is a typically readily available, off-the-shelf item, can be of various sizes and can contain various types of diluent. With the prefilled syringe body connected to the vial accessing adapter subassembly, a force exerted onplunger30 will cause the diluent to controllably flow into the medicament container MC. The inverted medicament container is then shaken to thoroughly intermix the powdered or lyophilized drug with the liquid diluent. This done, the reconstituted drug can be drawn into thesyringe assembly24 by withdrawing theplunger30 of the syringe body. Thesyringe assembly24 can then be removed from theadapter14 and in the manner shown by the solid lines inFIG. 3A, the syringe can be used to administer the reconstituted drug to the patient. It is to be appreciated that throughout this entire process, cannula orhypodermic needle42 has been maintained in a sterile configuration. Onlycannula18 has pierced the potentially contaminated rubber stopper RS of the medicament container andcannula42 has been completely protected against any possible contamination by the rubber stopper RS. Stated another way, during the entire process of reconstituting the powdered or lyophilized drug,cannula42 has been maintained in a virgin, sterile configuration and is completely free from any possible contamination at the time of administration of the reconstituted drug to the patient.
When the medicament to be delivered to the patient is contained within the medicament container and requires no reconstitution, the assembledsyringe24 can be mated with theadapter14 and the assembly thus formed can be directly mated with the medicament container MC. In this instance, during the mating step, theskirt portion20 of the adapter is snapped over the upper portion of the container and thecannula18 is urged into piercing engagement with the rubber stopper in the manner shown inFIG. 2A so as to open communication betweenlumen42aofcannula42 and the interior of the medicament container MC. The syringe assembly can then be used to withdraw the liquid medicament from the container intoreservoir32 of the syringe assembly. The syringe assembly can then be removed from theadapter14 and used to inject the medicament withinreservoir32 into a patient in a conventional manner. It is to be understood that, if desired, the syringe cannula assembly can first be connected to theadapter14 to form a container accessing subassembly comprising the syringe cannula assembly and theadapter14. The container accessing subassembly can then be mated with the medicament container so that thecannula18 pierces the rubber stopper. This done, the syringe body can be mated with the container accessing subassembly and by sliding the piston outwardly of the syringe body, the medicament can be removed from the container.
Turning next toFIGS. 4 and 4A, there is shown an alternate form of the vial accessing adapter means of the apparatus of the invention for the aseptic administration of medicaments contained within a medicament container. This alternate form of the invention is quite similar to the embodiment shown inFIGS. 1 through 3 and like numerals are used inFIGS. 4 and 4A to identify like components. The primary difference between this latest form of the invention and the earlier described embodiment resides in the fact that a filter means, shown here as aporous filter50, is provided withinlumen18aofcannula18.Filter50, which can be constructed from any suitable porous metal or ceramic material, is strategically positioned betweencannula42 and the open-end18aofcannula18. When positioned withincannula18, filter50 functions to effectively filter out any particular matter that may reside within the liquid medicament contained within medicament container MC.
Referring next toFIGS. 5 and 5A, an alternate form of vial accessing adapter means of the invention is there shown and generally designated by the numeral40. The vial accessing adapter means of this alternate form of the invention is somewhat similar to vial accessing adapter means of the embodiment of the invention shown inFIG. 1, but uniquely includes venting means for venting to atmosphere any gases that may reside within in the medicament container.
As shown inFIG. 5, this alternate form of vial accessing adapter means includes anadapter component44 that is preferably formed from a moldable plastic material.Adapter44 includes abody portion45 having a tapered bore45aand atop wall46 connected to the body portion. Anadapter cannula48 is integrally formed with and extends frombody portion45. A container connector means is connected totop wall46 for removably interconnecting the adapter component to a conventional medicament container MC, such as the container shown inFIG. 2. The container connector means of the present form of the invention here comprises a resilientlydeformable skirt50 that is integrally formed with and extends fromtop wall46 in the manner shown in the drawings. When the adapter component is mated with the medicament container,skirt50 telescopically receives and securely grips the upper portion of the medicament container in a manner such thatadapter cannula48 will completely pierce the rubber stopper of the container.
As before,plastic adapter cannula48 has a piercing extremity48aand alumen48bthat communicates with the interior of the medicament container when the adapter is interconnected with the container in the manner previously discussed herein. In this regard, it is to be noted that as in the earlier described embodiments,skirt50 is provided with a radially inwardly extendingshoulder50aand a plurality of circumferentially spacedslits50bthat enable the adapter of the invention to be snapped over the upper portion of the medicament container to securely grip the container in the manner shown inFIG. 2.
In this latest form of the invention,cannula48 is provided with avent passageway54 that also communicates with the interior of the medicament container. As best seen inFIG. 5A, ventpassageway54 communicates with atransversally extending passageway56 via afilter member58. Transversally extendingpassageway56, in turn, communicates with avent port60 formed intop wall46 of theadapter44. The vent passageways54 and56, along withvent port60, comprise the venting means of the form of the invention shown inFIGS. 5 and 5A. With the construction shown in these figure drawings, afterplastic cannula48 has pierced the rubber stopper of the medicament container, gases within the container can flow to atmosphere in the direction of the arrows shown inFIG. 5A and thereby affectively vent the interior of the container to atmosphere.
As before,body portion45 functions to removably interconnect a syringe assembly of the character previously described and as shown inFIG. 3A. As in the earlier described embodiments of the invention, the tapered bore45aofbody portion45 is adapted to sealably receive thesyringe cannula support41 of thesyringe cannula assembly26, or aspirator connector means, that comprisescannula support41 andsyringe cannula42 that is connected to thesyringe cannula support41. Once the aspirating means orsyringe body25 is interconnected with thesyringe cannula support41 in the manner previously described, the syringe assembly thus formed functions in the same manner as a conventional medicament administration syringe to reconstitute lyophilized drugs and to administer medicaments to a patient in a conventional manner.
Turning toFIG. 6, still another, alternate form of the vial accessing adapter means of the invention is there shown and generally designated by the numeral70. The vial-accessing adapter means of this alternate form of the invention is also somewhat similar to that shown inFIG. 1, but uniquely comprises anadapter72 that includes generally cylindrically shapedconnector skirt74.Adapter72 also includes abody portion75 having a tapered bore75a,atop wall76 connected to the body portion and anadapter cannula78 that is integrally formed with and extends frombody portion75.Connector skirt74 is connected totop wall46 and functions to removably interconnect the adapter component to a conventional medicament container such as the container MC shown inFIG. 2. When the adapter component is mated with the medicament container,skirt74 telescopically receives and securely grips the upper portion of the medicament container in a manner such thatadapter cannula78 will completely pierce the rubber stopper of the container.
As before,plastic adapter cannula78 has a piercing extremity78aand alumen78bthat communicates with the interior of the medicament container when the adapter is interconnected with the container in the manner previously discussed herein.
The tapered bore75aofbody portion75 is adapted to removably receive thesyringe cannula support82 of the syringe cannula assembly that comprisescannula support82 andsyringe cannula86 that is connected to thesyringe cannula support82. Once thesyringe body25 is interconnected with thesyringe cannula support82 in the manner previously described, the syringe assembly thus formed functions in the same manner as a conventional medicament administration syringe to reconstitute lyophilized drugs and to administer medicaments to a patient in a conventional manner.
Referring next toFIG. 7, yet another alternate form of the vial accessing adapter means of the invention is there shown and generally designated by the numeral90. The vial accessing adapter means of this alternate form of the invention is quite similar to that shown inFIG. 6 and like numerals are used inFIG. 7 to identify like components. The principal difference between the adapter means of the invention shown inFIG. 7 and that shown inFIG. 6 resides in the fact that the generally cylindrically shapedplastic skirt92 of theadapter93 is provided with acircumferentially extending protuberance92a.When the adapter of this alternate form of the invention is interconnected with the medicament container,protuberance92ais lockably received proximate the neck of the medicament container MC and functions to hold the adapter in position relative to the medicament container.
As in the earlier described embodiments,adapter93 includes atop wall96 and anadapter cannula98 that is integrally formed with and extends fromtop wall96.Connector skirt92 is also connected totop wall96 and functions to removably interconnect the adapter component to a conventional medicament container such as the container shown inFIG. 2. When the adapter component is mated with the medicament container,skirt92 telescopically receives the upper portion of the medicament container andprotuberance92agrips the neck of the container in a manner such thatadapter cannula98 completely pierces the rubber stopper of the container.
As before,plastic adapter cannula98 has a piercing extremity98aand alumen98bthat communicates with the interior of the medicament container when the adapter is interconnected with the container in the manner previously discussed herein.
Adapter93 includes a body portion94 to which thetop wall96 is connected, the body portion having a tapered bore94a.Cannula98 is integrally formed with and extends from body portion94 so that when the adapter component is mated with the medicament container, the adapter cannula pierces the stopper of the medicament container.Skirt92 telescopically receives and securely grips the upper portion of the medicament container and as in the earlier described embodiments of the invention, the body portion94 functions to sealably receive asyringe cannula support82 which is identical in construction and operation to that previously described.
Turning toFIG. 8, still another form of vial accessing adapter means of the invention for the aseptic administration of medicaments contained within a medicament container is there shown and generally designated by the numeral101. This latest form of the invention includes anadapter component102 that is somewhat similar to theadapter14 shown inFIG. 1, but does not include either a top wall or a resiliently deformable skirt for gripping the medicament container. Rather, theadapter component102 includes only a generally cylindrically shapedbody portion104 that is similar in configuration to the previously described adapter body portions. This generally cylindrically shapedbody portion104 ofadapter101 is provided with a tapered bore104athat is adapted to sealably receive asyringe cannula support108 to which asyringe cannula110 of asyringe cannula assembly111 is connected. Connected to and depending frombody portion104, is anadapter cannula106 having a piercing extremity106athat is adapted to pierce the rubber stopper of a conventional medicament container. As shown inFIG. 8,adapter cannula106 has a lumen106bthat is in communication with bore104aofbody portion104.
Once again, it is important to note that when thesyringe cannula support108 of the aspirator connector means is sealably received within tapered bore104aofbody portion104 in the manner shown inFIG. 8, the syringe cannula orhypodermic needle110 is once again strategically positioned within lumen106bof theadapter cannula106 and is therefore protected from contamination. Once thesyringe cannula assembly111 is interconnected with an aspirating means, such as the earlier described syringe body25 (FIG. 3), the syringe assembly thus formed functions in the same manner as a conventional medicament administration syringe and can be used to reconstitute lyophilized drugs and to administer medicaments to a patient in the manner previously described herein.
In accordance with an alternate form of the method of the invention for reconstituting a powdered or lyophilized drug, the sealed container containing the drug is first accessed using the vial accessingadapter subassembly101, which is of the character shown inFIG. 8. This accessing step is accomplished by exerting a force on thesubassembly101 that is sufficient to causeadapter cannula106 to pierce the rubber stopper so that the lumen106bofcannula106 as well as the lumen110aofcannula110 are in communication with the interior of the medicament container.
With the vial accessingadapter subassembly101 appropriately interconnected with the medicament container, the assemblage thus formed is inverted and a sealed syringe body, such assyringe body25 that has been prefilled with a suitable diluent is opened and is then connected to the vial accessingadapter subassembly101 by means of the luer connector108aformed onconnector member108. As before, the prefilled, sealedsyringe body25, or aspirator means, which is a typically readily available, off-the-shelf item, can be of various sizes and can contain various types of diluent. With the prefilled syringe body connected to the vial accessingadapter subassembly101, a force exerted on the plunger of the syringe will cause the diluent to controllably flow into the medicament container. The inverted medicament container is then shaken to thoroughly intermix the powdered or lyophilized drug with the liquid diluent. This done, the reconstituted drug can be aspirated into the syringe assembly by withdrawing the plunger of the syringe body. The syringe assembly can then be removed frombody104 and the syringe can be used to administer the reconstituted drug to the patient. It is to be appreciated that throughout this entire process, cannula orhypodermic needle110 has been maintained in a sterile configuration.Only cannula106 has pierced the rubber stopper of the medicament container andcannula110 has been completely protected against any possible contamination by the rubber stopper of the medicament container.
When the medicament to be delivered to the patient is contained within the medicament container and requires no reconstitution, an assembled syringe, such assyringe24, can be mated withbody104 ofadapter102 and the assembly thus formed can be directly mated with the medicament container. In this instance, during the mating step, thecannula106 is urged into piercing engagement with the rubber stopper so as to open communication between lumen106bofcannula106 and the interior of the medicament container. The syringe assembly can then be used to withdraw the liquid medicament from the container into the reservoir of the syringe assembly. The syringe assembly can then be removed frombody104 and used to inject the medicament within the reservoir into a patient in a conventional manner.
Turning now toFIG. 9, yet another alternate form of the vial accessing adapter means of the invention is there shown and generally designated by the numeral114. The vial accessing adapter means of this latest form of the invention is somewhat similar to the earlier described embodiments of the invention. However, one form of this latest embodiment of the invention uniquely comprises three cooperating components, namely a somewhat differently configuredadapter component116, a uniquely configuredneedle sheath118 and a differently configured a syringe, oraspirator connector assembly120 that is adapted for interconnection with an aspirator. As will be discussed in greater detail hereinafter, in still another form of the invention, theneedle sheath118 and theaspirator connector assembly120 are manufactured and provided to the user as a single, unitary assembly (seeFIG. 12A).
As in the earlier described embodiments,adapter116 includes atop wall121 and anadapter cannula122 that is integrally formed with and extends from top wall121 (see alsoFIG. 13). Connected to and extending fromtop wall121 in a first direction, is a resilientlydeformable skirt124 for receiving a portion of the medicament container. Skirt124 functions to removably interconnect the adapter component to a conventional medicament container MC (FIG. 2).Skirt124 is provided with a radially inwardly extendingshoulder124aand a plurality of circumferentially spacedslits124bthat enable the adapter component of the invention to be snapped over the upper portion of the medicament container MC. When the adapter component is mated with the medicament container,skirt124 telescopically receives the upper portion of the medicament container andprotuberance124agrips the neck of the container in a manner such thatadapter cannula122 completely pierces the rubber stopper of the container. As before,plastic adapter cannula122 has a piercingextremity122aand alumen122bthat communicates with the interior of the medicament container when the adapter is interconnected with the container in the manner previously discussed herein.
Connected to and extending fromtop wall121 in a second direction, is aconnector extension126. As best seen inFIG. 13 of the drawings,connector extension126 has anouter wall126aand aninner wall126bdefining abore128.
An important feature of this latest embodiment of the invention is the provision of a plurality of circumferentially spaced buttressmembers130 that are connected to the resilientlydeformable skirt124 in the manner best seen inFIGS. 14 and 15. In the present form of the invention, six identically constructed buttress members are connected to theskirt124 and each buttress member includes abody portion130athat terminates in a radially inwardly extending finger132 (FIG. 15). As best seen inFIG. 14 of the drawings, the plurality of buttress members cooperate to define a generally circular shapedopening134. For a purpose presently to be described, each of thebuttress members130 is movable between a first closed position and a second open position. To enable the expeditious plastic molding of the adapter unit,top wall121 is provided withclearance apertures121a.
Forming still another important aspect of the vial accessing adapter means of this latest form of the invention is previously identifiedneedle sheath assembly118 that is closely received within theopening134 defined by the six buttress members (FIGS. 9 and 15). In a manner presently to be described, this importantneedle sheath assembly118 functions to lockably receive and protectively enclose the needle of the previously identifiedsyringe connector assembly120.
Needle sheath assembly118 which is preferably constructed from a moldable plastic, includes aneedle sheath140 having a yieldably deformableouter wall142 that terminates in a generally annular shaped downwardly taperinglocking flange144 that defines an opening146 (FIG. 12). In a manner presently to be described, yieldably deformableouter wall142 that is provided with diametrically opposed longitudinally extending slits143 (FIGS. 14 and 15) is movable against the urging of biasing means, here provided in the form of anelastomeric band147 between a first closed position and a second open position to permit the insertion of thesyringe connector assembly120 into apassageway144 defined by theupper portion146aof aninner wall146 of the needle sheath (FIG. 12).Inner wall146 also includes alower portion146bwhich, as shown inFIG. 9, is closely received within thebore128 defined byconnector extension126. As best seen inFIGS. 9 and 11 of the drawings,outer wall140 of the needle sheath is interconnected withinner wall146 by means of afulcrum rib149.
Referring particularly toFIGS. 9 and 10 of the drawings, aspirator orsyringe connector assembly120 can be seen to be somewhat similar in construction to the earlier describedaspirator connector26 of the invention (FIG. 3) and includes anouter wall150 to which a downwardly extendinghypodermic needle152 having a piercingpoint152ais connected. Provided proximate the upper end ofouter wall150 is aconventional luer connector154 that permits thesyringe connector assembly120 to be interconnected with an appropriate aspirator such as the earlier described syringe28 (FIG. 3). A unique feature of the syringe connector assembly, oraspirator connector122, is the provision of a circumferentially extending, tapered lockingrim156 that functions to lockably engage the taperedflange144 of the needle sheath when the aspirator connector is in position within thesheath118 in the manner illustrated inFIG. 9 of the drawings. As illustrated inFIG. 9 of the drawings, lockingrim156 has anupper surface156athat lockably engagesflange144 and a lower taperedsurface156b.
The vial accessing adapter means of this latest form of the invention also includes filter means, shown here as aparticulate filter160, for filtering particulate matter from medicament aspirated from the medicament container. Additionally, the vial accessing adapter means further includes aneedle wiping member162 that is connected toconnector extension126 in the manner best seen inFIG. 9 of the drawings.
In using the vial accessing adapter of the invention, theadapter116 is first mated with the previously identified medicament container MC in the manner previously described. During the mating step, theskirt portion124 of the adapter is snapped over the upper portion of the container and theadapter cannula122 is urged into piercing engagement with the rubber stopper of the medicament container MC so as to open communication between the lumen of the cannula and the interior of the medicament container. This done, theneedle sheath118 is then mated with theadapter116 by inserting the needle sheath into theopening134 defined by the six circumferentially spaced apart buttressmembers130. As the needle sheath is inserted into theopening134,fingers132 will be urged radially outwardly in the direction of thearrows165 ofFIG. 9, causing theprotuberance124aof theskirt124 to be urged radially inwardly so as to securely grip the neck of the medicament container MC in a manner such thatadapter cannula122 completely pierces the rubber stopper of the container. As best seen inFIGS. 9 and 15, acircumferentially extending bead119 is provided on theneedle sheath118 so that as the needle sheath is inserted intoopening134 and is moved downwardly into the position shown inFIG. 9,bead119 will pass the buttress marking and impart a tactile sensation to the user indicating that the sheath is seated. As previously mentioned, as the needle sheath mates with the adapter, both the inner and outer walls of the needle sheath will sealably engage the inner surface of theconnector extension126.
Following mating of theneedle sheath118 with theadapter116, the next step in this latest form of the method of the invention is to mate thesyringe connector assembly120 with theneedle sheath118. This is accomplished by inserting the lower body portion of the connector assembly into theopening146 defined by the taperedflange144 of the needle sheath and exerting a downward force on the connector assembly. This downward force will cause the taperedlower surface156bof theconnector assembly rim156 to engage the tapered flange of the needle sheath in a manner to urge the outward movement of the deformableouter wall142 relative to fulcrum149 against the urging of theelastomeric band147. As the deformableouter wall142 moves into its open position,rim156 will bypass theflange144 and will move into the fully inserted position shown inFIG. 9 of the drawing and theelastomeric band147 will urge the deformableouter wall142 to return to its starting closed position. Movement of the connector assembly into a fully inserted position will cause the tapered outer wall of the connector assembly to move into sealing engagement with the inner surface of the upper portion of theinner wall146 of thesheath118. Movement of the connector assembly into a fully inserted position will also cause theneedle152 to pierce the elastomericneedle wiping member162 in the manner shown inFIG. 9 of the drawings.
With the vial accessing adapter of the invention in the configuration shown inFIG. 9, medicament can be drawn from the medicament container MC in the manner previously described herein. As the medicament is drawn from the container, it will be suitably filtered by theparticulate filter160.
As previously mentioned, in still another alternate form of the invention, theneedle sheath118 and thesyringe connector assembly120 are provided to the user as a single, unitary assembly (seeFIG. 12A). In this instance, following mating theadapter116 with the previously identified medicament container MC in the manner previously described, the assemblage made up of theneedle sheath118 and thesyringe connector assembly120 is then mated with theadapter116 by inserting the assemblage into theopening134 defined by the six circumferentially spaced apart buttressmembers130. As the assemblage is inserted into theopening134,fingers132 will be urged radially outwardly in the direction of thearrows165 ofFIG. 9 causing theprotuberance124aof theskirt124 to be urged radially inwardly so as to securely grip the neck of the medicament container MC. As illustrated inFIG. 9 of the drawings, as the assemblage is moved into the position shown inFIG. 9 of the drawings,bead119 will pass the buttresses creating a tactile sensation and theneedle152 will pierce the elastomericneedle wiping member162.
Following mating of the assemblage made up of theneedle sheath118 and thesyringe connector assembly120 with theadapter116, the next step in this latest form of the method of the invention is to mate the syringe with the assemblage in the manner previously described so that the medicament can be drawn from the container and suitably filtered by theparticulate filter160.
It is apparent from a study ofFIG. 9 that with the vial accessing adapter of the invention in the configuration shown inFIG. 9, thesyringe connector assembly120 is locked in position and cannot be removed from theneedle sheath118. Accordingly, when the user has finished filling the syringe, the assemblage made up of the syringe, the syringe connector assembly and the needle sheath can be separated from the adapter without using any special technique. This is made possible because the adapter will be securely held in place by the fact that the sheathouter walls140 prevent thebuttresses132 from flexing inwardly. This, in turn, preventssurfaces124aon the adapter legs from spreading out and freeing the adapter from the vial cap.
However, following removal from theadapter116 of the assembly, made up of theneedle sheath118 and thesyringe connector assembly120, a radially inward force exerted on the lower portions of the deformableouter wall142 will cause the upper portions of the outer wall of the needle sheath to move outwardly relative tofulcrum149 against the urging of theelastomeric band147. With the upper portions of the outer wall of the needle sheath in the open position, only then can thesyringe connector assembly120 be removed from the needle sheath. As thesyringe connector assembly120 is removed from the needle sheath, theneedle152 will be cleanly wiped by theneedle wiping member162, which here comprises a conventional elastomeric slit septum. Additionally, the septum advantageously seals the fluid access to the vial adapter once the needle sheath and the connector assembly are removed. This is doubly important with multiple-use applications where the user wants to maintain a sterile fluid path into the vial for repeated access, and also to essentially “seal” off the fluid path from the vial after use, preventing residual drug “mists” or leakage of dangerous or caustic drugs. Further, it is to be observed that the construction thus described provides a secure and tactile attachment in a closed system, once the device is attached to the drug vial. This closed system design significantly reduces the risk of any accidental drug “misting” or exposure to the outside air, especially important when working with dangerous or caustic drugs.
In yet another alternate form of the invention, theneedle sheath118, thesyringe connector assembly120 and the syringe are provided to the user as a single, unitary assembly. In this instance, following mating theadapter116 with the previously identified medicament container MC in the manner previously described, the assemblage made up of theneedle sheath118, thesyringe connector assembly120 and the syringe is then mated with theadapter116. This is accomplished by inserting the assemblage made up of theneedle sheath118 and thesyringe connector assembly120 into theopening134 defined by the six circumferentially spaced apart buttressmembers130. As this assemblage is inserted into theopening134,fingers132 will be urged radially outwardly in the direction of thearrows165 ofFIG. 9, causing theprotuberance124aof theskirt124 to be urged radially inwardly so as to securely grip the neck of the medicament container MC. As illustrated inFIG. 9 of the drawings, as the assemblages moved into the position shown, theneedle152 will pierce the elastomericneedle wiping member162.
Following mating of the assemblage made up of theneedle sheath118, thesyringe connector assembly120 and the syringe with theadapter116, the next step in this latest form of the method of the invention is to withdraw the medicament from the container for later injection into the patient.
In accordance with one form of the method of the invention for reconstituting lyophilized medicaments and for the injecting the reconstituted medicaments into the patient using vial accessing means described in the preceding paragraphs, the first step in the method involves mating the adapter with the medicament container in a manner to place the adapter cannula in communication with the interior of the medicament container. This done, the aspirator is connected to the assembly made up of the needle sheath and the syringe connector assembly to form an aspiration assembly. Next, the assembly made up of the needle sheath and the syringe connector assembly is inserted into the opening defined by the buttress members. Using the aspirator containing a fluid, the fluid contained within the aspirator is caused to controllably flow into the medicament container and the medicament within the container is intermixed with the fluid to form a reconstituted medicament. Next, using the aspirator, the reconstituted medicament is withdrawn from the container and the aspiration assembly is removed from the adapter. The next step in the method of the invention uniquely involves yieldably deforming the wall of the needle sheath and removing the syringe connector assembly from the needle sheath to form a combination aspirator and syringe connector assembly. Finally, using the combination aspirator and syringe connector assembly, the reconstituted medicament is injected into the patient in a manner well understood by those skilled in the art.
In accordance with an alternate form of the method of the invention for injecting medicaments into the patient using vial accessing means described in the preceding paragraphs, the adapter is first mated with the medicament container in a manner to place the adapter cannula in communication with the interior of medicament container. This done, the aspirator is attached to the assembly made up of the needle sheath and the syringe connector assembly to form an aspiration assembly. Next, the assembly made up of the needle sheath and the syringe connector assembly is inserted into the opening defined by the buttress members and using the aspirator, the medicament is withdrawn from the container. Following withdrawal of the medicament from the container, the aspiration assembly is removed from the adapter. This done, the lower portion of the wall of the needle sheath is yieldably deformed so as to permit the removal of the syringe connector assembly from the needle sheath to form a combination aspirator and syringe connector assembly. Finally, using the combination aspirator and syringe connector assembly, the medicament is injected into the patient in a manner well understood by those skilled in the art.
Turning toFIG. 10A of the drawings, an alternate form of the syringe connector assembly of the invention is there shown and generally designated by the numeral170.Syringe connector assembly170 is similar in construction and operation to previously identifiedsyringe connector assembly120 and like numerals are used inFIG. 10A to identify like elements. The primary difference betweensyringe connector assembly120 andsyringe connector assembly170 resides in the fact that the piercingneedle172 is provided in the form of a blunt end cannula having ablunt piercing point172a.Blunt end cannulas are well known in the art and are used with conventional slit septums of a character also well known in the prior art.
In using the vial accessing adapter means of the invention which embodies the piercingneedle172, following reconstitution of the drug in the manner previously described, instead of injecting the patient in a conventional manner with an injection needle having a sharp point, the caregiver will inject the drug into an intravenous “Y” site, or like injection site, that embodies a conventional slit septum or swabable valve.
Turning next toFIGS. 16 and 17, there is shown an alternate form of the vial accessing adapter means of the apparatus of the invention for the aseptic administration of medicaments contained within a medicament container. This alternate form of the invention, which is generally designated by the numeral179, is somewhat similar to the embodiments shown inFIGS. 9 through 12A and like numerals are used inFIGS. 16 and 17 to identify like components. This latest form of the vial accessing adapter here comprises an aspirator, orsyringe connector assembly120 that includes anouter wall150 to which a downwardly extendinghypodermic needle152 having a piercingpoint152ais connected. Provided proximate the upper end ofouter wall150 is aconventional luer connector154 that permits thesyringe connector assembly120 to be interconnected with an appropriate aspirator such as the earlier described syringe28 (FIG. 3). As previously mentioned, a unique feature of the syringe connector assembly oraspirator connector120, is the provision of a circumferentially extending, tapered lockingrim156 that functions to lockably engage the tapered flange180aof theneedle sheath180 of the invention when the aspirator connector is in position within the sheath.
The vial accessing adapter means of this latest form of the invention also includes filter means, shown here as aparticulate filter182, for filtering particulate matter from medicament aspirated from the medicament container. Additionally, the vial accessing adapter means further includes aneedle wiping member184 that is connected to theneck portion186 of thevial accessing adapter190 of this latest form of the invention in the manner best seen inFIG. 16 of the drawings. An important feature of the apparatus of this latest form of the invention resides in the provision of acircumferentially extending protuberance186bthat is formed on the external surface ofneck portion186. The purpose of this protuberance will presently be described.
Thevial accessing adapter190 of this latest form of the invention which is preferably formed from a moldable plastic material, includes atop wall192, theneck portion186 that has a tapered bore186athat is connected to the top wall and anadapter cannula196 that is integrally formed with and extends fromtop wall192. A container connector means is also connected totop wall192 and functions to removably interconnect the adapter component with a conventional medicament container MC the character of which is shown inFIG. 2. The container connector means of this latest form of the invention here comprises a resilientlydeformable skirt198 that is integrally formed with and extends fromtop wall192 in the manner shown in the drawings. When the adapter component is mated with the medicament container,skirt198 telescopically receives and securely grips the upper portion of the medicament container in a manner such thatadapter cannula196 will completely pierce the rubber stopper RS of the container (FIG. 2A) so as to open communication between lumen of the cannula and the interior of the medicament container.
Once thevial accessing adapter190 is mated with the medicament container, theneedle sheath180 is mated with theadapter190 by inserting theneck portion186 of the adapter into theopening201 defined by theskirt portion203 of theneedle sheath180. As best seen by referring toFIG. 17, the inner wall203aof theskirt portion203 of the needle sheath is provided with acircumferentially extending groove205. As illustrated inFIG. 16 of the drawings, when theneck portion186 of theadapter190 is inserted into theopening201, the previously mentioned circumferentially extendingprotuberance186bthat is formed on theneck portion186 snaps into thegroove205 so as to securely lock together theneedle sheath180 and thevial accessing adapter190.
Following mating of theneedle sheath180 with thevial accessing adapter190, thesyringe connector assembly120 is mated with the needle sheath. This is accomplished by inserting the lower body portion of the connector assembly into theopening208 defined by the tapered flange180aof the needle sheath and exerting a downward force on the connector assembly. This downward force will cause the taperedlower surface156bof theconnector assembly rim156 to engage the tapered flange of the needle sheath in a manner to urge the outward movement of the deformable outer wall208arelative to fulcrum210 against the urging of theelastomeric band212. As the deformableouter wall208 moves into its open position,rim156 will bypass the flange180aand will move into the fully inserted position shown inFIG. 16 of the drawing and theelastomeric band212 will urge the deformableouter wall208 to return to its starting closed position. Movement of the connector assembly into a fully inserted position will also cause theneedle152 to pierce the elastomericneedle wiping member184 in the manner shown inFIG. 16 of the drawings.
With the vial accessing adapter of the invention in the configuration shown inFIG. 16, medicament can be drawn from the medicament container MC in the manner previously described herein. As the medicament is drawn from the container, it will be suitably filtered by theparticulate filter182.
As in the earlier described embodiments of the invention,plastic adapter cannula196 has a piercingextremity196aand alumen196bthat communicates with the interior of the medicament container MC when the adapter component is interconnected with the container. In this regard, it is to be noted thatskirt198 is provided with a radially inwardly extending shoulder198aand a plurality of circumferentially spacedslits198bthat enable the adapter component of the invention to be snapped over the upper portion of the medicament container MC to securely grip the container in the manner shown inFIG. 2.
Referring next toFIGS. 18 and 19 of the drawings, yet another form of the vial accessing adapter means of the apparatus of the invention is there shown and generally designated by the numeral218. This alternate form of the invention is quite similar to the embodiment shown inFIGS. 16 and 17 and like numerals are used inFIGS. 18 and 19 to identify like components. The primary difference between this latest form of the invention in the embodiment shown inFIGS. 16 and 17 resides in the fact that, as will presently be described, the vial accessing adapter is securely interconnected with the needle sheath by the frictional engagement between the outer wall of the neck portion of the vial accessing adapter and the inner wall of the skirt portion of the needle sheath.
As best seen inFIG. 19 of the drawings, the aspirator orsyringe connector assembly120 of this latest form of the invention is substantially identical in construction and operation to that of the embodiment ofFIGS. 16 and 17. Similarly, thevial accessing adapter220 of this latest form of the invention is substantially identical in construction and operation to thevial accessing adapter190 save for the fact that the outer wall of theneck portion222 is not provided with a circumferentially extending protuberance, such asprotuberance186bof the earlier described embodiment. Rather, the outer wall of theneck portion222, which is connected totop wall224, is tapered so that when the vial accessing adapter is mated with the needle sheath of this latest embodiment in the manner shown inFIG. 18, it will move into close frictional engagement with the inner wall226aof theskirt portion226 of theneedle sheath228. In view of this novel construction, in this latest embodiment of the invention the inner wall226aof the skirt portion is not provided with a circumferentially extending groove and the vial accessing adapter is securely interconnected with the needle sheath by the frictional engagement between the outer wall of theneck portion222 of the vial accessing adapter and the inner wall226aof theskirt portion226 of the needle sheath.
With the vial accessing adapter of the invention in the configuration shown inFIG. 18, medicament can be drawn from the medicament container MC in the manner previously described herein. As the medicament is drawn from the container, it will be suitably filtered by theparticulate filter182.
Turning now toFIGS. 20,21 and22 of the drawings, still another form of the vial accessing adapter means of the apparatus of the invention is there shown and generally designated by the numeral230. This alternate form of the invention is also somewhat similar to the embodiment shown inFIGS. 16 and 17 and like numerals are used inFIGS. 20 through 22 to identify like components. The primary difference between this latest form of the invention and the embodiment shown inFIGS. 16 and 17 resides in the fact that, as will presently be described, the vial accessing adapter is securely interconnected with the needle sheath by means of a threaded connection.
As best seen inFIG. 22 of the drawings, the aspirator orsyringe connector assembly120 of this latest form of the invention is substantially identical in construction and operation to that of the embodiment ofFIGS. 16 and 17. Similarly, thevial accessing adapter234 of this latest form of the invention is substantially identical in construction and operation to thevial accessing adapter190 save for the fact that the outer wall of theneck portion236 is not provided with a circumferentially extending protuberance, such asprotuberance186bof the embodiment ofFIG. 17. Rather, the outer wall of the neck portion, which is connected totop wall238, is provided with anexternal thread240, which in a manner presently to be described, threadably mates with aninternal thread242 that is formed on the inner wall244aof theskirt portion244 of theneedle sheath248 of this latest embodiment of the invention.
When the vial accessing adapter is mated with theneedle sheath248 of this latest embodiment in the manner shown inFIG. 21,external thread240 of the vial accessing adapter will be received withininternal thread242 of the needle sheath in a manner to securely interconnect the components.
With the vial accessing adapter of the invention in the configuration shown inFIG. 21, medicament can be drawn from the medicament container MC in the manner previously described herein. As the medicament is drawn from the container, it will be suitably filtered by theparticulate filter182.
As in the earlier described embodiments of the invention,plastic adapter cannula196 has a piercingextremity196aand alumen196bthat communicates with the interior of the medicament container MC when the adapter component is interconnected with the container. In this regard, it is to be noted thatskirt198 is provided with a radially inwardly extending shoulder198aand a plurality of circumferentially spacedslits198bthat enable the adapter component of the invention to be snapped over the upper portion of the medicament container MC to securely grip the container in the manner shown inFIG. 2.
Referring next toFIG. 23 of the drawings, yet another form of the needle sheath of the apparatus of the invention is there shown and generally designated by the numeral250. This alternate form of needle sheath is quite similar to the previously described needle sheaths of the invention and like numerals are used inFIG. 23 to identify like components. The primary difference between this latest form of the needle sheath and those previously described herein resides in the absence ofprotuberance186band in the differently configured inner wall, the lower portion of said inner wall thereof which here extends well beyond said lower portion of theouter wall251 of the needle sheath and which encapsulates saidneedle152 of the aspirator connector. More particularly, thelower portion252aof theinner wall252 is considerably elongated so as to extend well beyond the lower portion of theouter wall251 of the needle sheath and well beyond theneedlepoint152aof the needle. With this novel construction, the elongatedlower portion252aof theinner wall252 functions to protect theneedlepoint152afrom contamination and also ensures that the needlepoint retains its sharpness. Additionally, the elongatedlower portion252aof the inner wall provides a useful means for interconnecting the needle sheath with ampules of conventional construction.
Turning now toFIGS. 24 and 25 of the drawings, still another form of the vial accessing adapter means of the apparatus of the invention for the aseptic administration of medicaments contained within a medicament container. This alternate form of the invention, which is generally designated by the numeral256, is somewhat similar to the embodiment shown inFIGS. 16 and 17 and like numerals are used inFIGS. 24 and 25 to identify like components. This latest form of the vial accessing adapter here comprises an aspirator orsyringe connector assembly258, that includes anouter wall260 to which a downwardly extendinghypodermic needle262 having a piercingpoint262ais connected. Provided proximate the upper end ofouter wall260 is aconventional luer connector154 that permits thesyringe connector assembly258 to be interconnected with an appropriate aspirator such as the earlier described syringe28 (FIG. 3). As previously mentioned, a unique feature of the syringe connector assembly, oraspirator connector258, is the provision of a circumferentially extending, tapered lockingrim266 that functions to lockably engage the tapered flange268aof theneedle sheath268 of this latest form of the invention when the aspirator connector is in position within the sheath.
The vial accessing adapter means of this latest form of the invention also includes filter means, shown here as aparticulate filter182, for filtering particulate matter from medicament aspirated from the medicament container. Additionally, although not necessary in this latest form of the invention, the vial accessing adapter means further includes aneedle wiping member184 that is connected to theneck portion186 of thevial accessing adapter190 of this latest form of the invention.Vial accessing adapter190 is substantially identical in construction and operation to that described in connection with the embodiment ofFIGS. 16 and 17.
As before, when the adapter component is mated with the medicament container,skirt198 telescopically receives and securely grips the upper portion of the medicament container in a manner such thatadapter cannula196 will completely pierce the rubber stopper RS of the container (FIG. 2A) so as to open communication between the lumen of the cannula and the interior of the medicament container.
The primary difference between theaspirator connector258 of this latest form of the invention and the aspirator connector of the embodiment of the invention shown inFIG. 17 of the drawings, resides in the provision of acollapsible needle protector272 that is connected to theouter wall260 of the aspirator connector.Collapsible needle protector272 is movable from the first expanded position shown inFIG. 24 to the second collapsed position shown inFIG. 25. As indicated inFIG. 24 of the drawings, when the needle protector is in the first expanded position it encapsulates the downwardly extendingneedle262 of the aspirator connector, including the piercingpoint262a.
Needle protector272, which includes a compressible, accordion likeside wall272a,is preferably constructed from a yieldable material and is constructed and arranged to fit snugly around the needle proximate thehub area273 of theouter wall260. With the unique construction thus described, when theaspirator connector258 is mated with theneedle sheath268 in the manner illustrated inFIG. 25 of the drawings, thesidewall272aof the needle protector is collapsed so as to expose the lower extremity of theneedle262. However, when theaspirator connector258 is removed from the needle sheath, the snug fit collapsible needle protector will wipe the needle clean and will move into the expanded, needle protection configuration shown inFIG. 24 of the drawings. With the needle protector in this expanded configuration, it not only protects the needle from damage, but also importantly protects the user from needle stick.
Once thevial accessing adapter190 is mated with the medicament container, theneedle sheath268 is mated with theadapter190 by inserting theneck portion186 of the adapter into theopening275 defined by theskirt portion277 of the needle sheath. With the vial accessing adapter of the invention in the configuration shown inFIG. 25, medicament can be drawn from the medicament container MC in the manner previously described herein. As the medicament is drawn from the container, it will be suitably filtered by theparticulate filter182.
Referring now toFIGS. 26 and 27, still another form of the vial accessing adapter subassembly of the invention is there shown and generally identified by the numeral278. This latest adapter subassembly is similar to that illustrated inFIG. 1 of the drawings and like numerals are used inFIGS. 26 and 27 to identify like components. More particularly, the vial-accessingadapter subassembly278 here includes anadapter component14 that is substantially identical in construction and operation to that illustrated and described in connection with the embodiment ofFIG. 1.Adapter component14 includes abody portion15 having a tapered bore15a,atop wall16 connected to the body portion, and anadapter cannula18 that is integrally formed with and extends frombody portion15.
Acontainer connector assembly282 of the character illustrated inFIG. 26 of the drawings is also connected totop wall16 and functions to removably interconnect the adapter component with a conventional medicament container MC (FIG. 2). The primary difference between the container connector means of this latest form of the invention and the connector means of the embodiment ofFIG. 1, resides in the provision of aconnector assembly282 of a novel construction.Connector assembly282 which is connectable toadapter component14, here comprises ahousing284 that includes a downwardly extendingprotector sleeve286 that is constructed and arranged to extend into thelumen18aof thecannula18 of the adapter component. As shown inFIG. 26,housing284 houses thebarrel portion41 of theconnector assembly26, which is substantially identical in construction and operation to that illustrated inFIG. 1 of the drawings and earlier described herein. As depicted inFIG. 27 of the drawings, when theconnector assembly282 is mated with theadapter component14,protector sleeve286 extends into thelumen18aof theadapter cannula18 and circumscribes and substantially encapsulates thesyringe cannula42 of theconnector assembly26. With this novel construction the user can remove the syringe cannula from the drug vial and still maintain a protective covering that protects the syringe cannula from contamination. Additionally theprotective covering286 advantageously maintains the sharpness of the cannula and also effectively protects the user against needle stick.
In the manner illustrated inFIG. 27 of the drawings, thecontainer connector assembly282 of this latest form of the invention can be sealably connected tobody portion15 of the vial accessing adapter means of the invention and the apparatus can then be used in the manner previously described.
Having now described the invention in detail in accordance with the requirements of the patent statutes, those skilled in this art will have no difficulty in making changes and modifications in the individual parts or their relative assembly in order to meet specific requirements or conditions. Such changes and modifications may be made without departing from the scope and spirit of the invention, as set forth in the following claims.